Rethinking Regulatory Protections for Accelerated Approvals With Supplementary Indications
Journal of Clinical Oncology · 20.11.2026 · 44 (33) · 3184-3188
DOI: 10.1200/jco-26-00627 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Oncology, erschienen am 20.11.2026. Verfasst von Catherine S Hwang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of General Internal Medicine and Geriatrics, Oregon Health and Science University, Portland, OR. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of General Internal Medicine and Geriatrics, Oregon Health and Science University, Portland, OR.
- Section of General Internal Medicine, VA Portland Health Care System, Portland, OR.
- University of Alabama School of Law, Tuscaloosa, AL.
ORCID-Profile: Catherine S Hwang
Zitieren
APA
Hwang, C. S., Gerrity, M. S., & Tu, S. S. (2026). Rethinking Regulatory Protections for Accelerated Approvals With Supplementary Indications. Journal of Clinical Oncology, 44(33), 3184-3188. https://doi.org/10.1200/jco-26-00627
Vancouver
Hwang CS, Gerrity MS, Tu SS. Rethinking Regulatory Protections for Accelerated Approvals With Supplementary Indications. Journal of Clinical Oncology. 2026;44(33):3184-3188. doi:10.1200/jco-26-00627
BibTeX
@article{Hwang2026,
author = {Hwang, Catherine S and Gerrity, Martha S and Tu, S Sean},
title = {Rethinking Regulatory Protections for Accelerated Approvals With Supplementary Indications},
journal = {Journal of Clinical Oncology},
year = {2026},
volume = {44},
number = {33},
pages = {3184--3188},
doi = {10.1200/jco-26-00627}
}
EUVIMED